Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
ID: 322177Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/322177

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-20-043.html
Timeline
    Description

    The National Institutes of Health (NIH) is inviting applications for Cancer Center Support Grants (CCSGs) aimed at enhancing cancer research within NCI-designated Cancer Centers. This funding opportunity, specifically the P30 Clinical Trial Optional grants, is designed to support both Comprehensive Cancer Centers and Cancer Centers that integrate various research disciplines, fostering a collaborative environment to advance understanding and treatment of cancer. The CCSGs are crucial for establishing a robust research infrastructure that promotes innovative cancer research initiatives across the United States, with applications subject to peer review and a maximum budget limit for new and renewal requests. Interested applicants can find more information and guidelines at the NIH website, and the application deadline is set for October 12, 2121.

    Point(s) of Contact
    FBOWebmaster@OD.NIH.GOV
    Files
    Title
    Posted
    PAR-20-043.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is soliciting applications for Cancer Center Support Grants (CCSGs) aimed at promoting cancer research within NCI-designated Cancer Centers. This funding opportunity (PAR-20-043), particularly the P30 Clinical Trial Optional grants, supports comprehensive, clinical, and basic cancer centers to foster a collaborative research environment that integrates various scientific disciplines. The initiative encourages applications from institutions with significant annual NIH cancer-focused funding and promotes innovative interactions, community engagement, and education within the realm of cancer research. The program not only aims to enhance the understanding of cancer but also to improve prevention, diagnosis, and therapeutic strategies, reflecting the NCI’s commitment to advancing cancer science and public health. Applications must comply with specified guidelines and are subject to peer review, with a maximum budget limit established for new and renewal applications. The CCSGs are foundational for research infrastructure, enabling extensive cancer-focused initiatives across the United States.
    Similar Opportunities
    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Funding Opportunity Announcement (FOA) for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers under the P30 activity code. These grants are designed to foster excellence in cancer research by integrating diverse research activities and enhancing collaboration among institutions, with eligible applicants including various educational and community organizations. The CCSGs emphasize a transdisciplinary approach to cancer research, with funding amounts of up to $1.2 million for Basic Cancer Centers and $1.4 million for Clinical Cancer Centers per year, potentially extending over five years based on merit. Interested parties can find more information and application details at the NIH website, and inquiries can be directed to the NIH OER Webmaster at FBOWebmaster@OD.NIH.GOV. The application deadline is set for October 12, 2121.
    Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for Cancer Center Support Grants (CCSGs) aimed at supporting NCI-designated Cancer Centers through the P30 funding mechanism. This initiative seeks to enhance collaborative cancer research across various domains, including basic laboratory, clinical, and prevention research, with eligibility extending to Comprehensive Cancer Centers, Clinical Cancer Centers, and Basic Cancer Centers that demonstrate significant research capabilities and community engagement. The funding, which has an award ceiling of $1.5 million, is intended to foster transdisciplinary research collaboration, create shared resources, and ensure equitable participation in cancer research across diverse populations. Interested applicants must submit their proposals by January 7, 2026, and can direct inquiries to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further information.
    Forecast to Publish a Funding Opportunity Announcement for Cancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is set to publish a Funding Opportunity Announcement for Cancer Center Support Grants (CCSGs) aimed at NCI-designated Cancer Centers. This initiative invites applications from small businesses to support various types of Cancer Centers, including Comprehensive, Clinical, and Basic Cancer Centers, with the goal of enhancing cancer research capabilities and fostering collaboration across institutional boundaries. The CCSGs are crucial for advancing the understanding of cancer and developing effective prevention, diagnosis, and treatment strategies. Interested applicants can reach out to the Office of Cancer Centers at the National Cancer Institute via email at ncicenters-r@mail.nih.gov or by phone at 240-276-5600. The estimated synopsis will be posted on October 1, 2025, with applications closing on January 25, 2026, and awards expected to be made by December 1, 2026.
    National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health, through the National Cancer Institute (NCI), invites applications for Program Project grants (P01) aimed at fostering collaborative, multidisciplinary cancer research for the years 2023, 2024, and 2025. Applicants must propose at least three interrelated research projects and an Administrative Core, all centered around a common theme within the expansive field of cancer research, which includes areas such as cancer biology, prevention, diagnosis, treatment, and control. This funding opportunity is crucial for advancing cancer research and enhancing the effectiveness of collaborative efforts, with applications due by May 7, 2026. Interested parties can find more information and application guidelines at the provided link, and inquiries can be directed to NIH Grants Information at grantsinfo@nih.gov.
    Core Centers for Clinical Research (CCCR) (P30 Clinical Trial Not Allowed)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Core Centers for Clinical Research (CCCR)" aimed at advancing methodological sciences in clinical research related to musculoskeletal, rheumatic, and skin diseases. This initiative seeks to establish centers that will focus on the prevention, diagnosis, and treatment of these conditions, emphasizing the development of novel methods and metrics while ensuring community representation throughout the research process. Eligible applicants include small businesses, with no cost-sharing or matching requirements, and the estimated project start date is set for July 1, 2027. Interested parties can reach out to Dr. Melissa C. Green Parker at melissa.greenparker@nih.gov or by phone at 240-755-3031 for further information, with the application period expected to close on September 25, 2026.
    Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Comprehensive Partnerships to Advance Cancer Health (CPACH) (U54 Clinical Trial Optional)" aimed at fostering long-term partnerships between Resource Limited Institutions (RLIs) and NCI-designated Cancer Centers (CCs). This initiative seeks to enhance cancer research by addressing disparities in cancer outcomes and promoting outreach and engagement across diverse populations. The program anticipates awarding approximately 12 cooperative agreements, with a minimum funding amount of $850,000, and key deadlines include an estimated synopsis close date of January 16, 2026, and an expected award date of September 1, 2026. For further inquiries, interested applicants can contact Dr. Sandra San Miguel-Majors at 240-276-5977 or via email at ncicpachU54@mail.nih.gov.
    Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the Cancer Prevention and Control Clinical Trials Planning Grant Program (R34), aimed at supporting the planning of clinical trials that enhance cancer prevention, detection, and survivorship. This program seeks to address critical gaps in preliminary data, participant recruitment strategies, and study designs necessary for finalizing trial protocols, thereby facilitating effective cancer intervention trials aligned with public health goals. Eligible organizations, including higher education institutions and nonprofits, can apply for funding of up to $225,000 per year for a maximum of three years, with a requirement to submit a Plan for Enhancing Diverse Perspectives (PEDP) as part of their application. Interested applicants should note the open submission date of January 25, 2025, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov.
    Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the Cancer Prevention and Control Clinical Trials Planning Grant Program (U34), aimed at facilitating the planning of clinical trials that enhance cancer prevention, intervention, and survivor care. This program seeks to address critical information gaps that hinder effective trial protocols, including population characteristics and operational risks, by requiring applicants to submit a Plan for Enhancing Diverse Perspectives (PEDP) to promote inclusivity in research teams and participant recruitment. With funding of up to $225,000 per year available for planning initiatives, eligible organizations include higher education institutions, non-profits, and tribal governments, with a project period of up to three years. Interested applicants should note the submission deadline of January 25, 2025, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the NIDCD Clinical Research Center Grant (P50 Clinical Trial Optional) aimed at advancing the diagnosis, prevention, treatment, and amelioration of human sensory and communication disorders. This funding opportunity supports integrated, multidisciplinary research programs that include 3-4 synergistic research projects and an administrative core, with the possibility of 1-2 optional scientific cores, all centered around a unifying clinical theme. The maximum project period is five years, with budgets capped at $1,500,000 in direct costs per year for new applications. Eligible applicants include various organizations, excluding foreign entities, and are encouraged to consult with NIDCD staff prior to submission to ensure responsiveness. The application deadline is June 2, 2028, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Environmental Health Sciences Core Centers Program (P30 Clinical Trials Optional)
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Environmental Health Sciences Core Centers Program (EHSCC), aimed at establishing research hubs that focus on environmental health science. This program seeks to enhance understanding of the impact of environmental exposures on human health, with an emphasis on interdisciplinary collaboration among investigators and community engagement, as outlined in the NIEHS Strategic Plan for 2025-2029. Eligible applicants include a variety of organizations such as higher education institutions and nonprofits, with a requirement for demonstrated peer-reviewed research funding of at least $3 million annually. The NIH plans to commit $6 million to fund up to four awards, with the earliest application submission date set for February 18, 2025, and a final close date of January 29, 2027. For further inquiries, interested parties can contact NIH Grants Information at grantsinfo@nih.gov.